2European Association for the Study of the Liver. EASAL clinical practice guidelines : management of chronic hepatitis B. J Hepatol, 2009,50 : 227-242.
3Schiff E, Lai CL, Hadziyannis S, et al. Adefovir dipivoxil for waitlisted and post-liver transpiantation patients with lamivudine-resistant hepatitis B : final long-term results. Liver Transp1,2007 ,13 :349-360.
4Westland C, Delaney W, Yang H, et al. Hepatitis B virus genotypes and virologic response in 694 patients in phase ~I studies of adefovir dipivox- ill. Gastroenterology ,2003,125 : 107-116.
9Fontona RJ. Entecavir in decompensated HBV cirrhosis:The future is loo- king brighter. J Hepato1,2010,52 : 176-182.
10Shim JH, Lee HC, Kim KM, et al. Efficacy of entecavir in treatment-nave patients with hepatitis B virus-related decompensated cirrhosis. J Hepa- tol,2010,52 : 176-182.
2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
4Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量：830
6Liver Disease Committee,Chinese Association of Integrative Medicine..肝纤维化中西医结合诊疗指南[J].中华肝脏病杂志,2006,14(11):866-870. 被引量：270
7Liver Failure and Artficial Liver Group,Chinese Society of Infectious Diseases,Chinese Medical Association.肝衰竭诊疗指南[J].实用肝脏病杂志,2006,9(6):321-324. 被引量：189
9Seto WK, Lai CL, Yuen MF. Acute-on-chronic liver failure in chronic hepatitis B. J Gastroenterol Hepatol,2012 ,27 :662-669.
10Satin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure:consensus recommendations of the Asian Pacific As sociation for the stud- y of the liver ( APASL). Hepatol Int ,2009,3:269-282.
